학술논문
FDA Approval Summary: Mirvetuximab Soravtansine-Gynx for FRa-Positive, Platinum-Resistant Ovarian Cancer
Document Type
Article
Author
Dilawari, A.; Shah, M.; Ison, G.; Gittleman, H.; Fiero, M.H.; Shah, A.; Hamed, S.S.; Qiu, J.; Yu, J.; Manheng, W.; Ricks, T.K.; Pragani, R.; Arudchandran, A.; Patel, P.; Zaman, S.; Pierce, W.F.; Rahman, N.A.; Tang, S.; Amiri-Kordestani, L.; Roy, A.; Kalavar, S.; Ghosh, S.; Mixter, B.D.; Kluetz, P.G.; Pazdur, R.
Source
In: Clinical Cancer Research . (Clinical Cancer Research, 1 October 2023, 29(19):3835-3840)
Subject
Language
English
ISSN
15573265
10780432
10780432